OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Joseph Fomusi Ndisang

Joseph Fomusi Ndisang

Department of Physiology
College of Medicine
University of Saskatchewan
Canada
Tel: 306-966-6533
Fax: 306-966-6532

Biography

Joseph Fomusi Ndisang is an Associate Professor in the Department of Physiology of University of Saskatchewan College of Medicine. He received postdoctoral training in Physiology at the University Of Saskatchewan College Of Medicine from 200-2005. He received a PhD in Pharmacology Toxicology from the University of Florence, Italy, 2000. He received a Doctor of Pharmacy degree from University of Florence, Italy, in 1995. He has received several distinguished awards and distinctions including: Associate Fellow of the Scientific Council of the International College of Angelology (2007); Young Investigator Award by International College of Angelology (2007); Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); Young Investigator Award by the Society of Experimental Biology and Medicine (2005); Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award for Meritorious Research by the American Physiological Society (2005); and Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). He has served as peer-reviewed for several reputed journals and granting agencies in United States, United Kingdom and Canada. His research interest is mainly focused on investigation the role of the heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity.

Research

His research interest is mainly focused on investigation the role of the heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity.